Long-term price targets for specific equities like Aarti Drugs through the year 2030 are subject to broad macroeconomic variations, sector-specific API pricing cycles, and future corporate earnings growth. While specialized equity analysts construct long-term valuation models based on compounding expectations, exact targets shift continuously. What is your target investment horizon, risk tolerance, and portfolio allocation strategy?